The suitability of the 'emergency' foot-and-mouth disease antigens held by the International Vaccine Bank within a global context (Q33444445)

26 July 2017

The suitability of the 'emergency' foot-and-mouth disease antigens held by the International Vaccine Bank within a global context (English)

1 reference

26 July 2017

foot-and-mouth disease

1 reference

P V Barnett

1

1 reference

26 July 2017

A R Samuel

series ordinal

2

1 reference

26 July 2017

R J Statham

series ordinal

3

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

26 July 2017

1 reference

26 July 2017

19

1 reference

26 July 2017

15-16

1 reference

26 July 2017

2107-2117

1 reference

A recent history of foot-and-mouth disease

26 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900399-6

7 January 2021

Foot-and-mouth disease: the risk for Great Britain after 1992

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900399-6

7 January 2021

Genetic analysis of type O viruses responsible for epidemics of foot-and-mouth disease in North Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900399-6

7 January 2021

Dose-response relationships in a microneutralization test for foot-and-mouth disease viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900399-6

7 January 2021

Improved double-stranded DNA sequencing using the linear polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900399-6

7 January 2021

Antigenic variation in foot-and-mouth disease: studies based on the virus neutralization reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900399-6

7 January 2021

Rapid correlation between field isolates and vaccine strains of foot-and-mouth disease virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900399-6

7 January 2021

Emergency vaccination against foot-and-mouth disease: rate of development of immunity and its implications for the carrier state

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900399-6

7 January 2021

Emergency vaccination of sheep against foot-and-mouth disease: protection against disease and reduction in contact transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900399-6

7 January 2021

Emergency vaccination of pigs against foot-and-mouth disease: protection against disease and reduction in contact transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900399-6

7 January 2021

Serological and biochemical analysis of some recent type A foot-and-mouth disease virus isolates from the Middle East

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900399-6

7 January 2021

Generation of a subtype-specific neutralization epitope in foot-and-mouth disease virus of a different subtype

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900399-6

7 January 2021

Identification of a fifth neutralizable site on type O foot-and-mouth disease virus following characterization of single and quintuple monoclonal antibody escape mutants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900399-6

7 January 2021

Sequence variation in the gene for the immunogenic capsid protein VP1 of foot-and-mouth disease virus type A.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900399-6

7 January 2021

10.1016/S0264-410X(00)00399-6

Identifiers

DOI

1 reference

26 July 2017

1 reference